4D Molecular Therapeutics... (FDMT)

4.16

-0.37 (-8.17%)

At close: Mar 03, 2025, 3:59 PM

4.13

-0.48%

After-hours: Mar 03, 2025, 03:59 PM EST

4D Molecular Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-160.87M	-100.84M	-107.49M	-71.32M	-56.69M	-49.31M	-9.55M	-11.22M
Depreciation & Amortization	6.71M	5.75M	3.88M	3.02M	1.44M	1M	697K	626K
Stock-Based Compensation	26.12M	19.66M	17.12M	13.8M	4.98M	3.54M	1.38M	256K
Other Working Capital	n/a	-266K	255K	-14.72M	345K	-3.35M	-8.59M	19.03M
Other Non-Cash Items	-6.54M	-999K	1.14M	898K	48K	5.14M	2K	39K
Deferred Income Tax	n/a	n/a	n/a	n/a	20K	2.65M	n/a	n/a
Change in Working Capital	n/a	630K	-1.34M	-15.53M	-711K	259K	-8.78M	18.54M
Operating Cash Flow	-134.59M	-75.79M	-86.69M	-69.13M	-50.91M	-36.71M	-16.25M	8.24M
Capital Expenditures	n/a	-2.77M	-11.54M	-9.11M	-1M	-3.2M	-414K	-573K
Acquisitions	n/a	n/a	11.54M	9.11M	n/a	n/a	n/a	24K
Purchase of Investments	-467.65M	-54.8M	-153.31M	-168.57M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	169M	n/a	147.8M	5M	n/a	n/a	n/a	8.22M
Other Investing Acitivies	-3.79M	173.29M	-11.54M	-9.11M	-1M	n/a	n/a	24K
Investing Cash Flow	-302.44M	115.72M	-17.05M	-172.68M	-1M	-3.2M	-414K	7.67M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-2.27M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	337.25M	8.49M	3.08M	3.79M	73.33M	-10K	169.05M	n/a
Financial Cash Flow	337.25M	156.83M	3.08M	118.09M	278.98M	-2.19M	84.58M	16K
Net Cash Flow	-99.77M	196.76M	-100.65M	-123.72M	227.07M	-42.11M	67.91M	15.93M
Free Cash Flow	-134.59M	-78.56M	-98.22M	-78.24M	-51.91M	-39.91M	-16.67M	7.66M